17.8 C
New York
Tuesday, June 9, 2026

Tag: fluid overload

newssourceFORcompanyinformationcontent1marketreleases

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with...

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and AID Use

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial...

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT

Nuwellis Appoints John Erb as Chief Executive Officer

Nuwellis Announces Appointment of John Erb as Chief Executive Officer

Press release: Transparency Notification from Shareholders

Transparency Notification from Shareholders

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFluid overload

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers